Published in Pharma Investments, Ventures and Law Weekly, March 5th, 2006
The grant was funded by the National Institute of Neurological Disorders and Stroke and is being conducted in collaboration with scientists at Duke University.
"This SBIR grant helps validate the promise of our early-stage pipeline products," said Michael T. Flavin, PhD, chairman and CEO. "SBIR grant funding is a non-dilutive financing mechanism which has enabled Advanced Life...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly